Pinkal Desai

3.8k total citations · 1 hit paper
71 papers, 1.2k citations indexed

About

Pinkal Desai is a scholar working on Hematology, Cancer Research and Genetics. According to data from OpenAlex, Pinkal Desai has authored 71 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 23 papers in Cancer Research and 19 papers in Genetics. Recurrent topics in Pinkal Desai's work include Acute Myeloid Leukemia Research (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Pinkal Desai is often cited by papers focused on Acute Myeloid Leukemia Research (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Pinkal Desai collaborates with scholars based in United States, Israel and Canada. Pinkal Desai's co-authors include Gail J. Roboz, Michael S. Simon, Duane C. Hassane, Ellen K. Ritchie, Mónica L. Guzmán, Nuria Mencia-Trinchant, Michael Samuel, Sang‐Min Lee, Gloria Cheang and Oleksandr Savenkov and has published in prestigious journals such as Circulation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Pinkal Desai

64 papers receiving 1.2k citations

Hit Papers

Somatic mutations precede acute myeloid leukemia years be... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Somatic mutations precede acute myeloid leukemia years before diagnosis
    2018 384 citations Pinkal Desai, Nuria Mencia-Trinchant et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pinkal Desai United States 17 679 398 371 308 198 71 1.2k
Jane E. Churpek United States 18 621 0.9× 360 0.9× 241 0.6× 282 0.9× 161 0.8× 45 1.1k
Bertil Uggla Sweden 14 600 0.9× 485 1.2× 123 0.3× 195 0.6× 414 2.1× 31 1.1k
Haiyang Yun Germany 14 767 1.1× 652 1.6× 198 0.5× 277 0.9× 63 0.3× 25 1.1k
Arun Rangaswami United States 14 269 0.4× 263 0.7× 149 0.4× 315 1.0× 233 1.2× 35 1.1k
Mackenzie Bowman Canada 18 760 1.1× 462 1.2× 85 0.2× 169 0.5× 166 0.8× 45 1.4k
Stefan Wilop Germany 21 377 0.6× 631 1.6× 130 0.4× 188 0.6× 237 1.2× 48 1.1k
Angelo Guerrasio Italy 24 938 1.4× 787 2.0× 128 0.3× 547 1.8× 255 1.3× 105 1.7k
Marek Hus Poland 17 461 0.7× 366 0.9× 81 0.2× 239 0.8× 319 1.6× 110 869
Kenneth B. DeSantes United States 16 322 0.5× 275 0.7× 175 0.5× 108 0.4× 354 1.8× 32 1.1k
Anna Butturini United States 17 432 0.6× 258 0.6× 120 0.3× 183 0.6× 301 1.5× 48 1.1k

Countries citing papers authored by Pinkal Desai

Since Specialization
Citations

This map shows the geographic impact of Pinkal Desai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinkal Desai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinkal Desai more than expected).

Fields of papers citing papers by Pinkal Desai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pinkal Desai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinkal Desai. The network helps show where Pinkal Desai may publish in the future.

Co-authorship network of co-authors of Pinkal Desai

This figure shows the co-authorship network connecting the top 25 collaborators of Pinkal Desai. A scholar is included among the top collaborators of Pinkal Desai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pinkal Desai. Pinkal Desai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flowers, Christopher R., Veronica Leautaud, Pinkal Desai, et al.. (2025). Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach. Blood Cancer Discovery. 6(2). 79–93.
2.
Pershad, Yash, Md Mesbah Uddin, Jeffrey Haessler, et al.. (2025). Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women. Blood. 146(9). 1078–1087. 4 indexed citations
3.
Desai, Pinkal, Sagar Lonial, Amanda F. Cashen, et al.. (2024). A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies. Clinical Cancer Research. 30(21). 4844–4855. 15 indexed citations
4.
Chlebowski, Rowan T., Aaron K. Aragaki, Kathy Pan, et al.. (2024). Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women’s Health Initiative. Cancer. 130(18). 3147–3156. 15 indexed citations
5.
Jain, Akriti, Madelyn Burkart, Xiaoyue Ma, et al.. (2024). Assessing Role of Comorbidities in Treatment Selection for Older Patients with Acute Myeloid Leukemia. Blood. 144(Supplement 1). 2867–2867.
6.
Barac, Ana, Theodore M. Brasky, Aladdin H. Shadyab, et al.. (2023). Pre‐diagnosis lipid levels and mortality after obesity‐related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort. Cancer Medicine. 12(15). 16626–16636. 5 indexed citations
7.
8.
Osman, Afaf E.G., Nuria Mencia-Trinchant, Caner Saygin, et al.. (2022). Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood Advances. 7(9). 1910–1914. 8 indexed citations
9.
Lee, Dennis, Michael S. Samuel, Pinkal Desai, et al.. (2022). PTPN11 mutations Confer Adverse Outcomes and Therapy Resistance in Older Patients with Acute Myeloid Leukemia (AML). Blood. 140(Supplement 1). 3208–3209. 1 indexed citations
10.
Colunga‐Lozano, Luis Enrique, Fernando Kenji Nampo, Arnav Agarwal, et al.. (2022). Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis. PLoS ONE. 17(2). e0263240–e0263240. 2 indexed citations
11.
Patel, Sanjay S., Julia T. Geyer, Joelle Racchumi, et al.. (2021). Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML. Frontiers in Oncology. 11. 701318–701318. 13 indexed citations
12.
Haring, Bernhard, Alexander P. Reiner, Jingmin Liu, et al.. (2021). Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative. Journal of the American Heart Association. 10(5). e018789–e018789. 60 indexed citations
13.
Gergis, Usama, Tsiporah B. Shore, Sebastian Mayer, et al.. (2018). Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes. Biology of Blood and Marrow Transplantation. 25(3). 466–473. 1 indexed citations
14.
Goldberg, Aaron D., Chetasi Talati, Pinkal Desai, et al.. (2018). TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia. Blood. 132(Supplement 1). 1433–1433. 35 indexed citations
15.
Mencia-Trinchant, Nuria, Yang Hu, Bas J. Wouters, et al.. (2017). Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations. Journal of Molecular Diagnostics. 19(4). 537–548. 60 indexed citations
16.
Ritchie, Ellen K., Gail J. Roboz, Richard T. Silver, et al.. (2017). Incidence of Infections and Second Cancers in Philadelphia Chromosome-Negative Patients with Myeloproliferative Neoplasms Treated with Ruxolitinib. Blood. 130. 2910–2910. 2 indexed citations
17.
Ammann, Eric M., Matthew T. Drake, Robert B. Wallace, et al.. (2017). Incidence of hematologic malignancy and cause‐specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation. Cancer. 123(21). 4168–4177. 14 indexed citations
18.
Kane, Kathleen, Pinkal Desai, Michael Samuel, et al.. (2017). Factors Affecting Transfusion Utilization in Acute Myeloid Leukemia (AML) Patients Undergoing Initial Therapy. Blood. 130. 3870–3870.
19.
20.
Desai, Pinkal, et al.. (1993). The effectiveness of pre‐operative advice to stop smoking: a prospective controlled trial. Anaesthesia. 48(9). 816–818. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane E. Churpek Breakdown of academic impact, for papers by Bertil Uggla Breakdown of academic impact, for papers by Haiyang Yun Breakdown of academic impact, for papers by Arun Rangaswami Breakdown of academic impact, for papers by Mackenzie Bowman Breakdown of academic impact, for papers by Stefan Wilop Breakdown of academic impact, for papers by Angelo Guerrasio Breakdown of academic impact, for papers by Marek Hus Breakdown of academic impact, for papers by Kenneth B. DeSantes Breakdown of academic impact, for papers by Anna Butturini
Rankless by CCL
2026